Patent · US Active

Forms of bendamustine free base

US8076366B2 · kind B2 · utility

23Cited by
17References
33Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 14, 2010
Grant dateDec 13, 2011
Priority date
Expiry dateAug 2, 2030

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P35/02
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Novel polymorphic forms of bendamustine free base are described, including amorphous bendamustine free base, six anhydrous crystalline forms, four hydrate forms, and five solvate forms, with methods of their preparation and use also being described.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.